References
- Norris P G, Corbett M, Hawk J LM. Polymorphic light eruption: prevalence in Australia and England. Br J Dermatol 1994; 30: 62–4
- Murphy G M, Hawk J L. The prevalence of antinuclear antibodies in patients with apparent polymorphic light eruption. Br J Dermatol 1991; 125: 448–51
- Thune P, Jansen C, Wennersten G, et al. The Scandinavian multicentre photopatch test study 1980-1985: final report. Photodermatology 1988; 5: 261–9
- Murphy G M, Logan R A, Lovell C R, et al. Prophylactic PUVA and UVB therapy in polymorphic light eruption - a controlled trial. Br J Dermatol 1987; 116: 531–8
- Addo H, Sharma A. SC. UVB phototherapy and photochemotherapy (PUVA) in the treatment of polymorphic light eruption and solar urticaria. Br J Dermatol 1987; 116: 539–47
- Bisland D, George S A, Gibbs N K, et al. A comparison of narrow band phototherapy (TLOI) and photochemotherapy (PUVA) in the management of polymorphic light eruption. Br J Dermatol 1993; 129: 708–12
- Ortel B, Tanew A, Wolff K, et al. Polymorphous light eruption: action spectrum and photoprotection. J Am Acad Dermatol 1986; 14: 748–75